Market Cap

Oncolytics Biotech Inc. Market Capitalization:

C$105.6 Million

CAD as of July 1, 2024

US$76.9 Million

business Oncolytics Biotech Inc. Company Profile

Oncolytics Biotech Inc. Main Stock Listing

TSX: ONC

Market Capitalization History of Oncolytics Biotech Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Oncolytics Biotech Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 C$124.8 M -16.45%
Jan. 1, 2023 C$149.3 M 3.75%
Jan. 1, 2022 C$143.9 M -24.29%
Jan. 1, 2021 C$190.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Oncolytics Biotech Inc. Categories

Canada languages Healthcare languages Biotechnology
Canada Healthcare Canada Biotechnology

Stocks & Indices

Oncolytics Biotech Inc. has the following listings and related stock indices.


Stock: TSX: ONC

Stock: NASDAQ: ONCY

Stock: FSX: ONYN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.